Xin Feng

Xin Feng

US FDA
在 fda.hhs.gov 的电子邮件经过验证
被引用次数：2227
Regulatory Affairs CMC Pre-formulation Pharmaceutical Formulations Formulation Evaluation
Weikun Li

Weikun Li

Amgen
在 amgen.com 的电子邮件经过验证
被引用次数：1784
Pre-Formulation
Himanshu N. Bhatt

Himanshu N. Bhatt

The University of Texas
在 utep.edu 的电子邮件经过验证
被引用次数：903
Complex Generics Pre-formulation Drug delivery Pharmacokinetics
Wei Zhang

Wei Zhang

Principal Scientist, Genentech Inc.
在 gene.com 的电子邮件经过验证
被引用次数：799
Amorphous solid dispersion Pre-formulation Solid-state pharmaceutics Pharmaceutical formulation
Dev Prasad

Dev Prasad

Massachusetts College of Pharmacy and Health Sciences, Boston MA
在 my.mcphs.edu 的电子邮件经过验证
被引用次数：580
Amorphous solid dispersion Oral and Parenteral formulation development Pre-formulation
Ajay Saxena

Ajay Saxena

Group Leader/Lead Investigator, Biocon-BMS Research and Development Center
在 syngeneintl.com 的电子邮件经过验证
被引用次数：403
Pharmaceutics Pre-formulation Formulation Solid Dosage Form Development
Harsh S. Shah

Harsh S. Shah

Senior Scientist at Center for Pharma Crystallization (CfPC), J-Star Research Inc.
在 my.liu.edu 的电子邮件经过验证
被引用次数：402
Formulation pre-formulation solid-state characterization
Abhijeet Maurya

Abhijeet Maurya

Amgen Inc.
在 amgen.com 的电子邮件经过验证
被引用次数：371
Pharmaceutical Formulations Pre-formulation Amorphous solid dispersion Formulation Evaluation Regulatory Science
Kalpna Garkhal, PhD

Kalpna Garkhal, PhD

Assistant Professor, NIPER-A
在 niperahm.res.in 的电子邮件经过验证
被引用次数：349
Drug delivery Regenerative medicine Pre-formulation
Pratik Adhikary

Pratik Adhikary

Formulation Scientist
在 mail.umkc.edu 的电子邮件经过验证
被引用次数：266
Polymorphism Pre-formulation Phage Display Peptide therapeutics BBB peptide drug delivery
1 - 10